Southwest Cancéropôle

Southwest Cancéropôle (GSO) is one of seven national cancéropôles initiated in 2003, with the National Cancer Institute (INCa), under the Cancer Plan. For 10 years, this exemplary measure runs a dynamic network of cancer research by coordinating institutions, jurisdictions and disciplines for the benefit of the patient.


Cancéropôle GSO - figures

500 teams, including 140 in Toulouse
Complementary expertise spread over 4 regions:
- Aquitaine in Bordeaux
- Limousin in Limoges
- Languedoc-Roussillon in Montpellier and Nîmes
- Midi-Pyrenees in Toulouse

Nearly 2,500 people including:
- The Research Laboratories (Inserm, CNRS, University)
- Clinical services (5 and 3 Hospital Centres for the Fight Against Cancer)
- 7 pharmaceutical companies including Pierre Fabre-Médicaments and Sanofi
- Biotechnology Companies




Main coordination objective: to discover new diagnostic and therapeutic approaches to better meet the expectations of patients. It requires scientific action and structuring programs to:

  • Build a scientific actions in cancer research and in an inter-and transdisciplinary approach that relies on the synergy of skills and equipment of the 4 regions
  • Enhance translational research and links between researchers and clinicians, via the actions of scientific activities
  • Support the emergence, innovation and transfer to the patient
  • Encourage social and economic development and industrial partnerships in line with the recommendations of Cancer Plans and Strategy INCA

Cancéropôle GSO offers a nationwide network of high scientific competence. This is what allows Oncopole teams work with all the basic, clinical and industrial research teams in the Greater Southwest. The CAPTOR program, funded by the Big Loan, combines the Toulouse team, one team in Montpellier and one in Bordeaux.
Learn more about Southwest Cancéropôle:

Contact :
 CANCEROPOLE GSO - 5 avenue Irène Joliot-Curie - 31100 TOULOUSE
 05 82 95 13 92